medigraphic.com

2022, Number 1

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2022; 23 (1)

Characterization of patients with peripheral vascular diseases who died in a period of four years

Barnés DJA, Aguirre AME, Triana MME, Arpajón PY

Language: Spanish
References: 43
Page: 1-20
PDF size: 317.64 Kb.


ABSTRACT

Introduction: Peripheral vascular diseases are a global health problem because they are a major cause of disability.
Objective: Characterize patients with peripheral vascular diseases who died over a period of four years.
Method: A descriptive and analytical study was conducted in patients who died between January 2015 and December 2018. Socio-demographic and clinical variables were studied. Absolute and relative frequencies were estimated, as well as the mortality rate. The association between the variables with the direct cause of death was identified.
Results: 42.7% of diabetic patients died; of these, 57.5% were decompensated. High blood pressure, smoking and diabetes mellitus were the most frequent risk factors. The total mortality rate was 0.171/1000 admissions. The most frequent arterial diseases were AAA (28.1%) and diabetic angiopathy (25%); and, as part of the latter, foot angiopathy (25.7%). Aneurysmectomy with graft substitution represented the most performed revascularizing surgery (58.8%). Hypovolemic shock and pulmonary thromboembolism predominated as post-surgical complications (15.7%). Septic shock (31.6%) and bacterial bronchopneumonia (25.7%) were the direct causes of death.
Conclusions: It was possible to characterize patients with peripheral vascular diseases who died in the last four years, so they estimated the prevalence rate and the annual trend of mortality at the National Institute of Angiology and Vascular Surgery in that period; also, the variables associated with direct causes of death.


REFERENCES

  1. Aboyans V, Ricco JB, Bartelink ML, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39(9):763-816. DOI: https://doi.org/10.1093/eurheartj/ehx095

  2. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circulation Res. 2015;116(9):1509-26. DOI: https://doi.org/10.1161/CIRCRESAHA.116.303849

  3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. The Lancet. 2012;380(9859):2095-128. DOI: https://doi.org/10.1016/S0140-6736(12)61728-0

  4. Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global burden of Disease Study 2015. The Lancet. 2017;389(10082):1885-1906. DOI: https://doi.org/10.1016/S0140-6736(17)30819-X

  5. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension. Global hypertension practice guidelines. Hypertension. 2020;75:1334-57. DOI: https://doi.org/10.1161/hypertensionaha.120.15026

  6. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2020;41:255-323. DOI: https://doi.org/10.1093/eurheartj/ehz486

  7. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111-88 . DOI: https://doi.org/10.1093/eurheartj/ehz455

  8. Apovian CM, Aronne LJ. The 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline for the Management of Overweight and Obesity in Adults What Is New About Diet, Drugs, and for Obesity? Circulation. 2015;132:1586-91. DOI:https://doi.org/10.1161/circulationaha.114.010772

  9. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico 2019. La Habana: MINSAP; 2020 [acceso 03/05/2020]. Disponible en: Disponible en: http://files.sld.cu/bvscuba/files/2020/05/Anuario-Electrónico-Español-2019-ed-2020.pdf

  10. Gallardo UJ, Seuc AH, Chirino N, Puentes I, Rubio Y. Mortalidad por enfermedades vasculares periféricas en Cuba en el año 2005. Rev Cubana Invest Bioméd. 2008 [acceso 02/01/2020];27(2). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086403002008000200010&lng=es&nrm=iso

  11. Gallardo UJ, Seuc AH, Zangronis L, Rubio Y, Puentes I, López L, et al. Impacto de la mortalidad por enfermedades vasculares periféricas, Cuba 2000. Rev Cubana Angiol y Cir Vasc. 2005 [acceso 02/01/2020];6(1). Disponible en: Disponible en: http://bvs.sld.cu/revistas/ang/vol6_1_05/angsu0105.htm

  12. Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. The Lancet. 2016;388(10063):3060-73. DOI:https://doi.org/10.1016/S0140-6736(16)30514-1

  13. Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, et al. The postthrombotic syndrome: Evidence-based prevention, diagnosis, and treatment strategies. Circulation. 2014;130:1636-61. DOI: https://doi.org/10.1161/CIR.0000000000000130

  14. Yamagishi S. Diabetic macrovascular complications. Jpn J Clin Med. 2015 [access 02/01/2020];73(3):479-83. Available from: Available from: https://europepmc.org/article/med/25812377

  15. Miyata T, Moon IS, Rerkasem K, Shi Z, Antono D, Kim IJ. Diabetic complications and PAD. Ann Vasc Dis. 2016;9(2):135-47. DOI: https://doi.org/10.3400/avd.pad.16-01000

  16. Marone EM, Cozzolino P, Ciampichini R, Chiodini V, Ferraresi R, Rinaldi A, et al. Peripheral arterial disease in diabetic patients: a long-term population-based study on occurrence, outcomes and cost. J Cardiovasc Surg (Torino). 2018 [access 04/01/2020];59(4):572-9. Available from: Available from: https://www.minervamedica.it/en/journals/cardiovascular-surgery/article.php?cod=R37Y2018N04A0572

  17. Kent KC. Abdominal aortic aneurysms. N Engl J Med. 2014;371(22):2101-8. DOI: https://doi.org/10.1056/NEJMcp1401430

  18. Madika AL, Mounier-Vehier C, Azzaoui R. Optimizing medical treatment of abdominal aortic aneurysm: Interest of vascular centers. Presse Med. 2018;47(2):161-6. DOI: https://doi.org/10.1016/j.lpm.2018.01.019

  19. Jonas DE, Feltner C, Amick HR, Sheridan S, Zheng ZJ, Watford DJ, et al. Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the US Preventive Services Task Force screening for carotid artery stenosis. Ann Intern Med. 2014;161(5):336-46. DOI: https://doi.org/10.7326/M14-0530 La Habana: MINSAP

  20. World Health Organization (WHO). World health statistics 2018: monitoring health for the SDGs, sustainable development goals. Geneva; 2018 [acceso 03/05/2020]. Disponible en: Disponible en: https://apps.who.int/iris/handle/10665/272596

  21. Naranjo Hernández Y, Figueroa Linares M, Cañizares Marín R. Envejecimiento poblacional en Cuba. Gac Méd Espirit. 2015 Dic [acceso 08/01/2020];17(3):223-33. Disponible en: Disponible en: http://scielo.sld.cu/pdf/gme/v17n3/GME25315.pdf

  22. Organización Mundial de la Salud (OMS). Las enfermedades no transmisibles, un problema de salud de primer orden para el siglo xxi. En: Estadísticas Sanitarias Mundiales 2012; 2012 [acceso 30/01/2017]. p. 1-178. Disponible en: Disponible en: http://www.who.int/healthinfo/ES_WHS2012_Full.pdf

  23. Triana Mantilla ME, Zapata Vinent JA, Ameneiro Pérez S, Pol Marrón N, Llanes Barrios JA. Comportamiento de la hemoglobina glucosilada en diabéticos tipo 2 con macroangiopatía de los miembros inferiores. Rev Cubana Angiol y Cir Vasc. 2015 [acceso 21/02/2020];16(2):154-63. Disponible en: Disponible en: http://scielo.sld.cu/pdf/ang/v16n2/ang04215.pdf

  24. García García Y, Licea Puig E, Garciga Cardoso F, Álvarez Delgado Y, Barnés Domínguez JA, Almaguer García S, et al. Control glucémico en el proceso perioperatorio de los pacientes con diabetes Mellitus. Rev Cubana Endocrinol. 2012 Ene-Abr [acceso 21/02/2019];23(1). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S156129532012000100006

  25. García García Y, Barnés Domínguez JA, Valdés Pérez C, Concepción DR, Savigne Gutiérrez W. Estrategias intensivas de intervención en el paciente hospitalizado por pie diabético. Rev Cubana Angiol y Cir Vasc. 2012 [acceso 21/02/2019];13(2). Disponible en: Disponible en: http://bvs.sld.cu/revistas/ang/vol13_2_12/ang07212.htm

  26. González Casanova JM, Valdés Chávez RC, Álvarez Gómez AE, Toirac Delgado K, Casanova Moreno MC. Factores de riesgo de aterosclerosis en adultos mayores diabéticos de un consultorio médico. Rev Uni Méd Pin. 2018 [acceso 18/02/2020];14(2):121-8. Disponible en: Disponible en: https://www.medigraphic.com/pdfs/revunimedpin/ump-2018/ump182e.pdf

  27. Santana López S, Montero Díaz R, Sánchez Fuentes AL, Valdés Vento AC, Vidal Vega IC. Caracterización de los factores de riesgo de la aterosclerosis. Rev Ciencias Méd. 2016 [acceso 18/02/2020];20(1). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942016000100025&lng=es

  28. Carter BD, Abnet CC, Feskanich D. Smoking and mortality: beyond established causes. N Engl J Med. 2015;372:631-40. DOI: 10.1056/NEJMsa1407211.

  29. Nativel M, Potier L, Alexandre L, Baillet-Blanco L, Ducasse E, Velho G, et al. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review. Cardiovasc Diabetol. 2018;17:138-42. DOI: https://doi.org/10.1186/s12933-018-0781-1

  30. De la Cruz Fornaguera Y, Barnés Domínguez JA. Tabaquismo y enfermedad arterial periférica. Rev Cubana Angiol y Cir Vasc. 2013 [acceso 21/03/2020];14(1). Disponible en: Disponible en: http://bvs.sld.cu/revistas/ang/vol14_1_13/angio05113.htm

  31. Malyar NM, Freisinger E, Meyborg M, Lüders F, Gebauer K, Reinecke H, et al. Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome. J Diab Compl. 2016;30(6):1117-22. DOI: https://doi.org/10.1016/j.jdiacomp.2016.03.033

  32. Hoffstad O, Mitra N, Walsh J, Margolis DJ. Diabetes, lower-extremity amputation, and death. Diabetes Care. 2015;38(10):1852-7. DOI: https://doi.org/10.2337/dc15-0536

  33. Thorud JC, Plemmons B, Buckley CJ, Shibuya N, Jupiter DC. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: A systematic review. J Foot Ankle Surg. 2016;XXX:1-9. DOI: https://doi.org/10.1053/j.jfas.2016.01.012

  34. Rivero Fernández FE, Álvarez Varona A, Conde Pérez P, Bernal Velíz R. Incidencia de amputaciones por pie diabético en la provincia Camagüey. Rev Cubana Angiol y Cir Vasc. 2005 [acceso 21/02/2019];6(1). Disponible en: Disponible en: http://bvs.sld.cu/revistas/ang/vol6_1_05/ang04105.htm

  35. López Gort S, Triana Mantilla ME, Pantaleón Bernal OS. Comportamiento de las amputaciones mayores causadas por enfermedad vascular periférica durante un semestre. Rev Cubana Angiol y Cir Vasc. 2013 [acceso 21/04/2019];14(2). Disponible en: Disponible en: http://bvs.sld.cu/revistas/ang/vol14_2_13/ang04213.htm

  36. Clavijo Rodríguez T, Valencia Díaz E, Barnés Domínguez JA, Carballo Tores L, Ortega Rodríguez O, Guevara Alfayate L. Aspectos clínicos y epidemiológicos de los aneurismas de la aorta abdominal. Rev Cubana Angiol y Cir Vasc. 2014 [acceso 21/02/2020];15(1). Disponible en: Disponible en: http://bvs.sld.cu/revistas/ang/vol15_1_14/ang04114.htm

  37. Bautista González S, Guzmán Chávez OR, Sandoval Virgen FG. Aneurisma aórtico abdominal. Rev Méd. 2012 [acceso 21/02/2017];3(4). Disponible en: Disponible en: http://www.medigraphic.com/pdfs/revmed/md-2012/md124g.pdf

  38. Karthikesalingam A, Holt PJ, Vidal-Diez A, Ozdemir BA, Poloniecki JD, Hinchliffe RJ, et al. Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA. The Lancet. 2014;383:963-9. DOI: https://doi.org/10.1016/S0140-6736(14)60109-4

  39. Karthikesalingam A, Wanhainen A, Holt PJ, Vidal-Diez A, Brownrigg JR, Shpitser I, et al. Comparison of long-term mortality after ruptured abdominal aortic aneurysm in England and Sweden. Br J Surg. 2016;103:199-206. DOI: https://doi.org/10.1002/bjs.10049

  40. Hernández Seara A, Cabrera Zamora J, Viña Cisneros H, Hondares Guzmán MC, López Díaz M, Licort García E, et al. Resultados de la cirugía convencional de los aneurismas de la aorta abdominal en el Instituto de Angiología y Cirugía Vascular. Rev Cubana Angiol y Cir Vasc. 2011 [acceso 15/05/2020];12(1). Disponible en: Disponible en: http://bvs.sld.cu/revistas/ang/vol12_01_11/ang06111.htm

  41. Romero Sánchez RE, Landín Sorí M, García Rodríguez M. Actualidad en infecciones quirúrgicas. Rev Arch med Camagüey. 2012 [acceso 15/05/2020];6(4):1507-17. Disponible en: Disponible en: http://revistaamc.sld.cu/index.php/amc/article/download/256/354

  42. Abascal Cabrera M, González Rubio R, La Rosa Domínguez A, Ulloa Quintanilla F. Repercusión de la bronconeumonía en la mortalidad hospitalaria. Rev Cubana Med Mil. 2001 [acceso 15/05/2020];30(2). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S013865572001000200005&nrm=iso

  43. García Gómez A, Almeida Correa E, Santamaría Fuentes S, Pérez Pérez O, Gutiérrez Gutiérrez L. Correlación clínica y patológica del tromboembolismo pulmonar. Rev Cubana Med Mil. 2016 [acceso 24/05/2020];45(1). Disponible en: Disponible en: http://bvs.sld.cu/revistas/mie/vol2_4_03/mie02403.htm




2020     |     www.medigraphic.com